Regulations.gov document
Reference 135 - Whitworth, H.S. Clinical utility of existing and second-generation…
Supporting & Related Material · FDA-2024-D-3863 · posted Jan 7, 2025
Key facts
| Document ID | FDA-2024-D-3863-0138 |
|---|---|
| Title | Reference 135 - Whitworth, H.S. Clinical utility of existing and second-generation interferon-γ release assays for diagnostic evaluation of tuberculosis: an observational cohort study. Lancet Infect Dis. 2019 Feb;19(2):193-202. |
| Document type | Supporting & Related Material |
| Subtype | Background Material |
| Agency | FDA |
| Docket | FDA-2024-D-3863 |
| Posted | Jan 7, 2025 |
At a glance
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: